Evaxion Biotech logo

Evaxion Biotech

EVAX | NASDAQ
Chart Builder DCF Calculator
$2.77
+$0.03 (+0.96%)
At close: Nov 16, 2026, 4:00 PM ET
$2.77
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:10 PM ET
+0.96%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
56.2
Fundamentals Strong
Market Sentiment Neutral
Moat None
Sector Rank #165/1021 (Top 16%)

Key Statistics

Market Data

Market Cap $17.5M
1D Range
2.77 2.89
52W Range
2.74 6.63

Valuation (TTM)

PE -0.45
PB 1.84
EV/EBITDA -1.07

Valuation (NTM)

Forward PE 84.28
Forward PEG 0.00
Price Target $9.50
Loading financial charts...

Profile

Evaxion Biotech A/S is a clinical-stage biotechnology firm dedicated to creating artificial intelligence-driven immunotherapies. Its innovative pipeline targets cancers, bacterial infections, and vira...

Sector Healthcare
Industry Biotechnology
Employees 46
IPO Date Feb 5, 2021
Website evaxion.ai
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Nov 19, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$9.50
Upside
+242.96%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.